MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease

    M. Fabbri, P. Chatkaew, C. Artusi, A. Romagnolo, M. Rizzone, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: To investigate the long-term effect of levodopa-carbidopa intestinal gel (LCIG) on axial signs in Parkinson's disease (PD) patients and the related prognostic factors. Background:…
  • 2019 International Congress

    Diagnostic accuracy of Progressive Supranuclear Palsy: Experience of a movement disorders center

    M. Gultekin (Kayseri, Turkey)

    Objective: The purpose of this paper is to emphasize the importance of correct diagnosis in PSP. Background: Progressive supranuclear palsy (PSP) is a commonly disease…
  • 2019 International Congress

    Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy

    G. Hoeglinger, D. Oleske, J. Zamudio, R. Diegidio, J. Holman (Munich, Germany)

    Objective: To evaluate the frequency of prescription medications commonly associated with the management of PSP in the community. Background: Progressive Supranuclear Palsy (PSP) is a…
  • 2019 International Congress

    Vascular Parkinsonism and Parkinson’s Disease: clinical differences concerning balance impairment

    R. Jesus, R. Raimundo, C. Azoia, M. Mendes, V. Espirito-Santo, A. Almeida, I. Rego, AG. Velon (Vila Real, Portugal)

    Objective: Determine and compare lower body predominance and balance between Vascular Parkinsonism (VP) and Parkinson’s Disease (PD)patients in a hospital-based sample. Background: Despite the recognition…
  • 2019 International Congress

    Non-motor symptoms and risk of functional dependency in early Parkinson’s disease

    R. Kim, D. Yoo, JH. Im, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: To determine whether non-motor symptoms predict the development of functional dependency in Parkinson’s disease (PD). Background: Non-motor symptoms are increasingly recognized as an integral…
  • 2019 International Congress

    Speculation on the timing of iron deposition in the putamen of patients with multiple system atrophy: multimodal MRI study

    MJ. Lee, JH. Lee (Yangsan-Si, Republic of Korea)

    Objective: We sought to investigate the temporal pattern of iron deposition in  the putamen of patients with multiple system atrophy (MSA)  by calculating conditional probabilities…
  • 2019 International Congress

    Increased vesicular monoamine transporter alleviate MPTP-induced impairment of neurogenesis

    K. Ma, G. Zhang, C. Han, X. Guo, Y. Xia, F. Wan, L. Kou, S. Yin, L. Liu, N. Xiong, J. Huang, T. Wang (Wuhan, China)

    Objective: In this study, we employed vesicular monoamine transporter 2–overexpressing mice (VMAT2-HI) to investigate the influence of increased vesicular storage of catacholamines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced…
  • 2019 International Congress

    Amimia in Parkinson’s Disease and its Relationship with Motor and Non-Motor Symptoms

    T. Maycas-Cepeda, C. Feliz-Feliz, L. Gomez-Vicente, R. García-Cobos, P. Lopez-Ruiz, R. Arroyo, PJ. García- Ruiz (Pozuelo de Alarcon, Spain)

    Objective: To asses the correlation of amimia (facial bradykinesia) with motor and non-motor symptoms (cognition and depression) in Parkinson´s disease (PD) patients. Background: Reduced facial expression,…
  • 2019 International Congress

    Identification of protein biomarker/s in CSF of Parkinson’s disease (PD) with cognitive impairment

    A. Naskar, A. Stezin, D. Gadara, S. Ahuja, V. Menon, N. Kamble, J. Saini, S. Hegde, U. Tatu, P. Pal, P. Alladi (Bangalore, India)

    Objective: i. To identify CSF protein biomarker/s in Parkinson's disease (PD) with cognitive impairment using LC-MS/MS proteomics. ii. To estimate the level of known AD…
  • 2019 International Congress

    Cognitive dysfunction can predict the body weight loss in patients with Parkinson’s disease

    RW. Ou, QQ. Wei, YB. Hou, XQ. Yuan, HF. Shang (Chengdu, China)

    Objective: The objective of this study was to examine the predictors of body weight loss in PD patients over years. Background: Early body weight loss…
  • « Previous Page
  • 1
  • …
  • 182
  • 183
  • 184
  • 185
  • 186
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley